The WHO-ISoP Pharmacovigilance Curriculum: 2026 Update
by Beckmann J et alITADs long-term evaluation of the UK Government’s flagship Fleming Fund has informed strategic shifts relating to data use and gender equity to reduce disease, illness and death from drug resistance.
The sixth and final Fleming Fund Fellows Symposium explored how the fellows' learning and development have made a lasting impact on the healthcare sector, building expertise nationally and globally.
AMR is an important global public health challenge, but there is a lack of good data on response progress. This study addresses country governance of antimicrobial resistance (AMR) surveillance, considering changes in responses to the Tracking Antimicrobial Resistance Country Self-Assessment Survey (TrACSS) between 2019 and 2024. Its first objective is to describe progress under the global action agenda on AMR. Its second objective is to assess the effectiveness of a major development aid intervention to encourage action against AMR, the United Kingdom (UK)-funded Fleming Fund (FF). The study applies a pragmatic approach to analysis, involving descriptive exploration and difference-in-differences methodology.
The latest paper from the Fleming Fund Regional Grant team, GEAR up, argues that current action on AMR fails to adequately address the social and political determinants that create vulnerability and the (gendered) power relations sustaining inequity.
GRAM opens global AMR data repository to researchers
by FlemingfundThe Global Research on Antimicrobial Resistance (GRAM) Project is inviting researchers worldwide to access and utilise its extensive antimicrobial resistance (AMR) data repository, hosted by the Infectious Diseases Data Observatory (IDDO).
The World Health Organization (WHO) has released its Global Antibiotic Resistance Surveillance Report 2025, revealing that one in six bacterial infections worldwide in 2023 were resistant to antibiotics.
The largest retrospective study on antibiotic resistance (AMR) in Africa highlights the need for major investments to enhance laboratory capabilities and healthcare access.
Two landmark projects aimed at strengthening the Caribbean’s capacity to fight antimicrobial resistance (AMR) were launched on 5 May, at an event in Barbados with regional and international health leaders in attendance.
A free online programme developed by the Fleming Fund and The Open University to strengthen the global response to antimicrobial resistance (AMR) has been relaunched with updated content across all 25 courses.
WHO releases Global AMU data to guide progress against AMR
by FlemingfundA major driver of AMR is the inappropriate use of antimicrobials. This is a common issue in many resource-limited countries with poor access to the correct medicines and treatment.
The Burnet Institute, Fleming Fund Country Grant lead for Papua New Guinea, unveiled two national AMR laboratories, marking a significant milestone for PNG healthcare.
The GRAM project led by Institute for Health Metrics and Evaluation and the University of Oxford and funded by the UK Department of Health and Social Care’s Fleming Fund and Wellcome, released the latest GRAM paper, published in The Lancet.
12 Dec 2023 Webinar where experts on gender and antimicrobial resistance (AMR) discuss key issues such as:
- What difference does gender and sex make to who carries the greatest burden of AMR in a community?
- How does gender intersect with other social and cultural factors to intensify vulnerability to AMR?
- What are the implications of these insights for health researchers, donors and policymakers?
Using intersectionality to study gender and antimicrobial resistance in low- and middle-income countries
by JMC Gautron et alDifferent sexes and genders experience differentiated risks of acquiring infections, including drug-resistant infections, and of becoming ill. Different genders also have different health-seeking behaviours that shape their likelihood of having access to and appropriately using and administering antimicrobials. Consequently, they are distinctly affected by antimicrobial resistance (AMR). As such, it is crucial to incorporate perspectives on sex and gender in the study of both AMR and antimicrobial use in order to present a full picture of AMR’s drivers and impact.
Tackling pandemics through a One Health approach
by FlemingfundThe Quadripartite’s One Health Joint Plan of Action promotes an interdisciplinary approach to tackling global health threats.
New data visualisation tool launched by Global Research on AMR project provides new insights into AMR globally
by FlemingfundInsights into the country level AMR burden data available for first time. The Global Research on AMR (GRAM) project, made up of the Institute for Health Metrics and Evaluation (IHME) and University of Oxford, have released a new visualisation (‘viz’) tool.
A new report is calling for a drastic increase in AMR data across the continent.
The Fleming Fund 2021 Annual Review
by FlemingfundThe Fleming Fund's 2021 Annual Review is now available.
The Fleming Fund Phase I: A Summary - Accessible Version
by FlemingfundAn accessible version of the Fleming Fund's Phase I Report is available here.